Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1563383/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823859177064235008 |
---|---|
author | Jesse Haramati Fabiola Solorzano-Ibarra Fabiola Solorzano-Ibarra Dallas B. Flies |
author_facet | Jesse Haramati Fabiola Solorzano-Ibarra Fabiola Solorzano-Ibarra Dallas B. Flies |
author_sort | Jesse Haramati |
collection | DOAJ |
format | Article |
id | doaj-art-650ef046679c47a1bd0fb63101fcb57f |
institution | Kabale University |
issn | 1664-3224 |
language | English |
publishDate | 2025-02-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj-art-650ef046679c47a1bd0fb63101fcb57f2025-02-11T07:00:05ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-02-011610.3389/fimmu.2025.15633831563383Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapyJesse Haramati0Fabiola Solorzano-Ibarra1Fabiola Solorzano-Ibarra2Dallas B. Flies3Laboratorio de Inmunología Traslacional, Departamento de Biología Celular y Molecular, Centro Universitario de Ciencias Biológicas y Agropecuarias, Universidad de Guadalajara, Zapopan, Jalisco, MexicoEstancias Posdoctorales por México, Consejo Nacional de Humanidades, Ciencias y Tecnologías (CONACHYT), México City, MexicoInstituto en Investigación en Enfermedades Crónico Degenerativas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, MexicoNextCure, Inc., Beltsville, MD, United Stateshttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1563383/fullICI Immunotherapycancertumorpersonalized & precision medicinecheckpoint blockade (ICB) therapy |
spellingShingle | Jesse Haramati Fabiola Solorzano-Ibarra Fabiola Solorzano-Ibarra Dallas B. Flies Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy Frontiers in Immunology ICI Immunotherapy cancer tumor personalized & precision medicine checkpoint blockade (ICB) therapy |
title | Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy |
title_full | Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy |
title_fullStr | Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy |
title_full_unstemmed | Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy |
title_short | Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy |
title_sort | editorial beyond pd 1 novel checkpoint receptors and ligands as targets for immunotherapy |
topic | ICI Immunotherapy cancer tumor personalized & precision medicine checkpoint blockade (ICB) therapy |
url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1563383/full |
work_keys_str_mv | AT jesseharamati editorialbeyondpd1novelcheckpointreceptorsandligandsastargetsforimmunotherapy AT fabiolasolorzanoibarra editorialbeyondpd1novelcheckpointreceptorsandligandsastargetsforimmunotherapy AT fabiolasolorzanoibarra editorialbeyondpd1novelcheckpointreceptorsandligandsastargetsforimmunotherapy AT dallasbflies editorialbeyondpd1novelcheckpointreceptorsandligandsastargetsforimmunotherapy |